Daniel Van Plew
2018
In 2018, Daniel Van Plew earned a total compensation of $9M as Executive Vice President and General Manager, Industrial Operations and Product Supply at Regeneron Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $677,160 |
|---|---|
| Option Awards | $7,650,147 |
| Salary | $660,000 |
| Other | $19,915 |
| Total | $9,007,222 |
Van Plew received $7.7M in option awards, accounting for 85% of the total pay in 2018.
Van Plew also received $677.2K in non-equity incentive plan, $660K in salary and $19.9K in other compensation.
Rankings
In 2018, Daniel Van Plew's compensation ranked 834th out of 14,244 executives tracked by ExecPay. In other words, Van Plew earned more than 94.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 834 out of 14,244 | 94th |
Division Manufacturing | 280 out of 5,765 | 95th |
Major group Chemicals And Allied Products | 83 out of 2,128 | 96th |
Industry group Drugs | 65 out of 1,817 | 96th |
Industry Pharmaceutical Preparations | 44 out of 1,391 | 97th |
Source: SEC filing on April 26, 2019.
Van Plew's colleagues
We found four more compensation records of executives who worked with Daniel Van Plew at Regeneron Pharmaceuticals in 2018.
2018
Leonard Schleifer
Regeneron Pharmaceuticals
Chief Executive Officer
2018
George Yancopoulos
Regeneron Pharmaceuticals
Chief Scientific Officer
2018
Marion McCourt
Regeneron Pharmaceuticals
Senior Vice President, Commercial
2018
Robert Landry
Regeneron Pharmaceuticals
Chief Financial Officer
News
Regeneron Pharmaceuticals Executive Vice President and General Manager, Industrial Operations and Product Supply Daniel Van Plew's 2021 pay rises 1% to $8.8M
April 21, 2022
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2020 pay jumps 531% to $135M
April 23, 2021
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2019 pay slips 19% to $21M
April 24, 2020
Regeneron Pharmaceuticals CEO Leonard Schleifer's 2018 pay stays at $27M
April 26, 2019